Cargando…
Agreement of aptamer proteomics with standard methods for measuring venous thrombosis biomarkers
BACKGROUND: Venous thromboembolism (VTE) is a complex disease with an incidence rate of about 1 in 1000 per year. Despite the availability of validated biomarkers for VTE, unprovoked events account for 50% of first events. Therefore, emerging high‐throughput proteomics are promising methods for the...
Autores principales: | Faquih, Tariq, Mook‐Kanamori, Dennis O., Rosendaal, Frits R., Baglin, Trevor, Willems van Dijk, Ko, van Hylckama Vlieg, Astrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110437/ https://www.ncbi.nlm.nih.gov/pubmed/34013156 http://dx.doi.org/10.1002/rth2.12526 |
Ejemplares similares
-
Association of Remote History of Venous Thrombosis With Risk of Venous Thrombosis After Age 70 Years
por: Wang, Huijie, et al.
Publicado: (2022) -
Procoagulant factor levels and risk of venous thrombosis in the elderly
por: Wang, Huijie, et al.
Publicado: (2020) -
FFP2-mondmasker of chirurgisch mondkapje bij COVID-19
por: van Hylckama Vlieg, Astrid, et al.
Publicado: (2020) -
D‐dimer, thrombin generation, and risk of a first venous thrombosis in the elderly
por: Wang, Huijie, et al.
Publicado: (2021) -
Long-Term Survival in a Large Cohort of Patients with Venous Thrombosis: Incidence and Predictors
por: Flinterman, Linda E., et al.
Publicado: (2012)